Stable angina pectoris: 3. Medical treatment

C. Shub

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The therapeutic goals for the patient with angina pectoris are to minimize teh frequency and severity of angina and to improve functional capacity at a reasonable cost and with as few side effects as possible. An integrated approach necessitates attention to conditions that might be aggravating angina, such as anemia or hypertension. Alterations in life-style and personal habits, such as cessation of cigarette smoking, are often necessary and should be continually reinforced by the physician. Certain concomitant diseases, such as chronic obstructive pulmonary disease, may influence the selection of drug therapy. Nitrates, β-adrenergic blockers, and calcium entry blockers, and calcium entry blockers are the major classes of drugs that can be used alone or in combination in a program that is designed for the individual patient.

Original languageEnglish (US)
Pages (from-to)256-273
Number of pages18
JournalMayo Clinic Proceedings
Volume65
Issue number2
StatePublished - 1990
Externally publishedYes

Fingerprint

Stable Angina
Calcium
Adrenergic Antagonists
Angina Pectoris
Nitrates
Chronic Obstructive Pulmonary Disease
Habits
Life Style
Anemia
Smoking
Hypertension
Physicians
Costs and Cost Analysis
Drug Therapy
Therapeutics
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Stable angina pectoris : 3. Medical treatment. / Shub, C.

In: Mayo Clinic Proceedings, Vol. 65, No. 2, 1990, p. 256-273.

Research output: Contribution to journalArticle

Shub, C 1990, 'Stable angina pectoris: 3. Medical treatment', Mayo Clinic Proceedings, vol. 65, no. 2, pp. 256-273.
Shub, C. / Stable angina pectoris : 3. Medical treatment. In: Mayo Clinic Proceedings. 1990 ; Vol. 65, No. 2. pp. 256-273.
@article{9f1382dd5f0141fb91863511f337c9d5,
title = "Stable angina pectoris: 3. Medical treatment",
abstract = "The therapeutic goals for the patient with angina pectoris are to minimize teh frequency and severity of angina and to improve functional capacity at a reasonable cost and with as few side effects as possible. An integrated approach necessitates attention to conditions that might be aggravating angina, such as anemia or hypertension. Alterations in life-style and personal habits, such as cessation of cigarette smoking, are often necessary and should be continually reinforced by the physician. Certain concomitant diseases, such as chronic obstructive pulmonary disease, may influence the selection of drug therapy. Nitrates, β-adrenergic blockers, and calcium entry blockers, and calcium entry blockers are the major classes of drugs that can be used alone or in combination in a program that is designed for the individual patient.",
author = "C. Shub",
year = "1990",
language = "English (US)",
volume = "65",
pages = "256--273",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "2",

}

TY - JOUR

T1 - Stable angina pectoris

T2 - 3. Medical treatment

AU - Shub, C.

PY - 1990

Y1 - 1990

N2 - The therapeutic goals for the patient with angina pectoris are to minimize teh frequency and severity of angina and to improve functional capacity at a reasonable cost and with as few side effects as possible. An integrated approach necessitates attention to conditions that might be aggravating angina, such as anemia or hypertension. Alterations in life-style and personal habits, such as cessation of cigarette smoking, are often necessary and should be continually reinforced by the physician. Certain concomitant diseases, such as chronic obstructive pulmonary disease, may influence the selection of drug therapy. Nitrates, β-adrenergic blockers, and calcium entry blockers, and calcium entry blockers are the major classes of drugs that can be used alone or in combination in a program that is designed for the individual patient.

AB - The therapeutic goals for the patient with angina pectoris are to minimize teh frequency and severity of angina and to improve functional capacity at a reasonable cost and with as few side effects as possible. An integrated approach necessitates attention to conditions that might be aggravating angina, such as anemia or hypertension. Alterations in life-style and personal habits, such as cessation of cigarette smoking, are often necessary and should be continually reinforced by the physician. Certain concomitant diseases, such as chronic obstructive pulmonary disease, may influence the selection of drug therapy. Nitrates, β-adrenergic blockers, and calcium entry blockers, and calcium entry blockers are the major classes of drugs that can be used alone or in combination in a program that is designed for the individual patient.

UR - http://www.scopus.com/inward/record.url?scp=0025271226&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025271226&partnerID=8YFLogxK

M3 - Article

C2 - 1968113

AN - SCOPUS:0025271226

VL - 65

SP - 256

EP - 273

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 2

ER -